...
首页> 外文期刊>Critical reviews in clinical laboratory sciences >Sample management for clinical biochemistry assays: Are serum and plasma interchangeable specimens?
【24h】

Sample management for clinical biochemistry assays: Are serum and plasma interchangeable specimens?

机译:临床生物化学测定的样品管理:是血清和血浆可互换的标本吗?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The constrained economic context leads laboratories to centralize their routine analyses on high-throughput platforms, to which blood collection tubes are sent from peripheral sampling sites that are sometimes distantly located. Providing biochemistry results as quickly as possible implies to consolidate the maximum number of tests on a minimum number of blood collection tubes, mainly serum tubes and/or tubes with anticoagulants. However, depending on the parameters and their pre-analytical conditions, the type of matrix - serum or plasma - may have a significant impact on results, which is often unknown or underestimated in clinical practice. Importantly, the matrix-related effects may be a limit to the consolidation of analyses on a single tube, and thus must be known by laboratory professionals.The purpose of the present critical review is to put forward the main differences between using serum and plasma samples on clinical biochemistry analyses, in order to sensitize laboratory managers to the need for standardization. To enrich the debate, we also provide an additional comparison of serum and plasma concentrations for approximately 30 biochemistry parameters. Properties, advantages, and disadvantages of serum and plasma are discussed from a pre-analytical standpoint - before, during, and after centrifugation - with an emphasis on the importance of temperature, delay, and transport conditions. Then, differences in results between these matrices are addressed for many classes of biochemistry markers, particularly proteins, enzymes, electrolytes, lipids, circulating nucleic acids, metabolomics markers, and therapeutic drugs. Finally, important key-points are proposed to help others choose the best sample matrix and guarantee quality of clinical biochemistry assays. Moreover, awareness of the implications of using serum and plasma samples on various parameters assayed in the laboratory is an important requirement to ensure reliable results and improve patient care.
机译:受限制的经济背景导致实验室能够集中在高通量平台上的常规分析,其中血液收集管由有时远方定位的外围采样点。尽可能快地提供生物化学结果,以巩固最大数量的血液收集管,主要是血清管和/或带抗凝血剂的管。然而,取决于参数及其预分析条件,基质 - 血清或血浆的类型 - 可能对结果产生重大影响,这通常在临床实践中未知或低估。重要的是,与矩阵相关的效果可以是单个管上分析的整合的限制,因此必须通过实验室专业人员所知。目前批判性审查的目的是提出使用血清和血浆样品之间的主要差异关于临床生物化学分析,以使实验室管理人员敏感标准化的需求。为了丰富辩论,我们还提供血清和血浆浓度的额外比较约30个生物化学参数。从预分析的观点来看,在离心前,期间和之后讨论了血清和等离子体的性质,优点和缺点 - 重点是温度,延迟和运输条件的重要性。然后,针对许多类生物化学标记,特别是蛋白质,酶,电解质,脂质,循环核酸,代谢组科和治疗药物寻址这些基质之间的结果的差异。最后,提出了重要的关键点来帮助他人选择最佳的样本矩阵并保证临床生物化学测定的质量。此外,对实验室中测定的各种参数上使用血清和血浆样品的影响的意识是确保可靠的结果和改善患者护理的重要要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号